Axel Heidenreich, David Pfister. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Agents/therapeutic useContinuity of Patient CareDocetaxelDrug Resistance, NeoplasmHumansMaleNeoplasm MetastasisProstatic Neoplasms/drug therapyProstatic Neoplasms/pathologyTaxoids/therapeutic use
Substances: See more » Antineoplastic AgentsTaxoidsDocetaxelcabazitaxel
Year: 2012 PMID: 22964168 DOI: 10.1016/j.eururo.2012.08.048
Source DB: PubMed Journal: Eur Urol ISSN: 0302-2838 Impact factor: 20.096